These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30505594)

  • 1. Correlation of tumor size and survival in pancreatic cancer.
    Takahashi C; Shridhar R; Huston J; Meredith K
    J Gastrointest Oncol; 2018 Oct; 9(5):910-921. PubMed ID: 30505594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant therapy and pancreatic cancer: a national cancer database analysis.
    Shridhar R; Takahashi C; Huston J; Meredith KL
    J Gastrointest Oncol; 2019 Aug; 10(4):663-673. PubMed ID: 31392047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-agent neoadjuvant chemotherapy improves response and survival in patients with resectable pancreatic cancer.
    Blinn P; Shridhar R; Maramara T; Huston J; Meredith K
    J Gastrointest Oncol; 2020 Oct; 11(5):1078-1089. PubMed ID: 33209499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology.
    Stiles BM; Kamel MK; Harrison SW; Rahouma M; Lee B; Nasar A; Port JL; Altorki NK
    Ann Thorac Surg; 2019 Jan; 107(1):187-193. PubMed ID: 30278165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma.
    Khattab A; Patruni S; Abel S; Hasan S; Ludmir EB; Finley G; Monga D; Wegner RE; Verma V
    J Gastrointest Oncol; 2019 Oct; 10(5):918-927. PubMed ID: 31602330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant chemotherapy versus observation following neoadjuvant therapy and surgery for resectable stage I-II pancreatic cancer.
    Ma SJ; Serra LM; Bartl AJ; Han HR; Fekrmandi F; Iovoli AJ; Hermann GM; Yu H; Singh AK
    J Radiother Pract; 2022 Sep; 21(3):383-392. PubMed ID: 36016861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical fate of T0N1 esophageal cancer: results from the National Cancer Database.
    Takahashi C; Shridhar R; Huston J; Meredith K
    J Gastrointest Oncol; 2018 Oct; 9(5):880-886. PubMed ID: 30505590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer.
    Anderson E; LeVee A; Kim S; Atkins K; Guan M; Placencio-Hickok V; Moshayedi N; Hendifar A; Osipov A; Gangi A; Burch M; Waters K; Cho M; Klempner S; Chao J; Kamrava M; Gong J
    JAMA Netw Open; 2021 Dec; 4(12):e2138432. PubMed ID: 34889947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
    Wang H; Tang H; Fang Y; Tan L; Yin J; Shen Y; Zeng Z; Zhu J; Hou Y; Du M; Jiao J; Jiang H; Gong L; Li Z; Liu J; Xie D; Li W; Lian C; Zhao Q; Chen C; Zheng B; Liao Y; Li K; Li H; Wu H; Dai L; Chen KN
    JAMA Surg; 2021 May; 156(5):444-451. PubMed ID: 33729467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
    Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
    Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant Chemoradiation Shows No Survival Advantage to Chemotherapy Alone in Stage IIIA Patients.
    Krantz SB; Mitzman B; Lutfi W; Kuchta K; Wang CH; Howington JA; Kim KW
    Ann Thorac Surg; 2018 Apr; 105(4):1008-1016. PubMed ID: 29453000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic Significance of Complete Pathologic Response Obtained with Chemotherapy Versus Chemoradiotherapy in Gastric Cancer.
    Trumbull DA; Lemini R; Díaz Vico T; Jorgensen MS; Attwood K; Ji W; Brady M; Gabriel E; Kukar M
    Ann Surg Oncol; 2021 Feb; 28(2):766-773. PubMed ID: 32737698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
    Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
    Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
    Assi HA; Mukherjee S; Kunz PL; Machiorlatti M; Vesely S; Pareek V; Hatoum H
    Oncologist; 2020 Feb; 25(2):e276-e283. PubMed ID: 32043766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis.
    Li J; Zhao Q; Ge X; Song Y; Tian Y; Wang S; Liu M; Qiao X
    BMC Surg; 2021 Mar; 21(1):137. PubMed ID: 33731072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of neoadjuvant therapy on outcomes in patients with resectable carcinoma of esophagus and gastro-esophageal junction from a tertiary cancer care center in India.
    Rao T S; Raju KVVN; Patnaik SC; Reddy P; Saksena AR; Rajappa S; Mallavarapu KM; Santa A; Gudipudi D; Boleneni N; Usofi Z; Gujjuru S; Smith L; Are C; Nusrath S
    J Surg Oncol; 2021 Jun; 123(7):1547-1557. PubMed ID: 33650697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer.
    Lutfi W; Talamonti MS; Kantor O; Wang CH; Stocker SJ; Bentrem DJ; Roggin KK; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Am J Surg; 2017 Mar; 213(3):521-525. PubMed ID: 28089341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.